Csenge Advisory Group Takes Position in Clorox Company (The) (CLX)

Csenge Advisory Group acquired a new position in shares of Clorox Company (The) (NYSE:CLX) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,978 shares of the company’s stock, valued at approximately $525,000.

Several other institutional investors also recently made changes to their positions in CLX. FMR LLC grew its position in shares of Clorox Company (The) by 8.3% during the first quarter. FMR LLC now owns 105,949 shares of the company’s stock worth $14,285,000 after buying an additional 8,088 shares in the last quarter. Teachers Advisors LLC grew its position in shares of Clorox Company (The) by 62.7% during the first quarter. Teachers Advisors LLC now owns 246,103 shares of the company’s stock worth $33,182,000 after buying an additional 94,802 shares in the last quarter. Anchor Capital Advisors LLC grew its position in shares of Clorox Company (The) by 0.9% during the first quarter. Anchor Capital Advisors LLC now owns 121,828 shares of the company’s stock worth $16,426,000 after buying an additional 1,065 shares in the last quarter. Simmons Bank grew its position in shares of Clorox Company (The) by 1.8% during the first quarter. Simmons Bank now owns 2,761 shares of the company’s stock worth $373,000 after buying an additional 50 shares in the last quarter. Finally, Mission Wealth Management LLC grew its position in shares of Clorox Company (The) by 12.9% during the first quarter. Mission Wealth Management LLC now owns 2,671 shares of the company’s stock worth $360,000 after buying an additional 305 shares in the last quarter. 71.56% of the stock is owned by institutional investors and hedge funds.

CLX has been the subject of a number of research analyst reports. Jefferies Group LLC reaffirmed a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Morgan Stanley lowered their price target on Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a report on Wednesday, August 2nd. BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the company a “buy” rating in a report on Thursday, August 3rd. Finally, BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $128.72.

TRADEMARK VIOLATION WARNING: This article was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.com-unik.info/2017/11/04/csenge-advisory-group-takes-position-in-clorox-company-the-clx.html.

Shares of Clorox Company (NYSE CLX) traded up $0.09 during midday trading on Friday, reaching $128.11. The company’s stock had a trading volume of 1,084,436 shares, compared to its average volume of 1,120,000. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.58 and a current ratio of 1.10. The stock has a market capitalization of $16.52 billion, a PE ratio of 23.29, a P/E/G ratio of 3.53 and a beta of 0.39. Clorox Company has a one year low of $111.24 and a one year high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.41 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.36 EPS. equities analysts predict that Clorox Company will post 5.58 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be issued a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 annualized dividend and a yield of 2.62%. Clorox Company (The)’s dividend payout ratio (DPR) is 61.65%.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. In the last ninety days, insiders sold 21,242 shares of company stock valued at $2,944,449. Insiders own 1.00% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

What are top analysts saying about Clorox Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Clorox Company (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit